Ramsay Health Care Ltd (ASX: RHC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Ramsay Health Care Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $9.83 billion
P/E Ratio 34.14
Dividend Yield 1.86%
Shares Outstanding 230.83 million
Earnings per share 1.262
Dividend per share 0.85
Year To Date Return 25.35%
Earnings Yield 2.93%
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Ramsay Health Care Ltd (ASX: RHC)
    Latest News

    a woman
    ⏸️ Investing

    Beat the ASX with these 3 stocks: Westpac Banking Corp, Fortescue Metals Group Limited and Ramsay Health Care Limited

    Outperforming the ASX could prove to be an easier task with Westpac Banking Corp (ASX:WBC), Fortescue Metals Group Limited (ASX:FMG)…

    Read more »

    a woman
    ⏸️ Investing

    3 growth stocks to power your portfolio

    Invest the Warren Buffett Way for the long term with companies like Ramsay Health Care Limited (ASX:RHC), REA Group Limited…

    Read more »

    a woman
    ⏸️ Investing

    2 top stocks you need to know

    Ramsay Health Care Limited (ASX:RHC) and REA Group Limited (ASX:REA) both have exciting opportunities to grow profits.

    Read more »

    ⏸️ Investing

    Do you own these 3 large-cap growth stocks?

    These 3 large-cap growth stocks could be worth buying: QBE Insurance Group Ltd (ASX:QBE), AMP Limited (ASX:AMP) and Ramsay Health…

    Read more »

    a woman
    ⏸️ Investing

    Could these 4 stocks help fund your retirement?

    A legendary investor once only bought companies that he knew intimately, maybe you should too.

    Read more »

    ⏸️ Investing

    4 stocks you'd love to buy but probably shouldn't

    High P/E stocks can disappoint and be slammed by the market, but that doesn't mean I haven't got my eye…

    Read more »

    ⏸️ Investing

    Do you own these 12 blue chip growth stocks?

    You could have made a 34% return with these companies.

    Read more »

    ⏸️ Investing

    3 reasons to buy CSL Limited

    Here’s why you should add CSL Limited (ASX:CSL) and Ramsay Health Care Limited (ASX:RHC) to your portfolio.

    Read more »

    ⏸️ Investing

    Meet the 4 best healthcare stocks your money can buy

    High margins and seemingly endless growth runways are a potent growth combination not to be missed.

    Read more »

    a woman
    ⏸️ Investing

    These 4 high-quality ASX stocks are soaring this month

    Sirtex Medical Limited (ASX:SRX), Transfield Services Limited (ASX:TSE) and Iress Ltd (ASX:IRE) are leading the pack in August and September.

    Read more »

    a woman
    ⏸️ Investing

    4 rock-solid growth prospects for the year ahead

    Oil Search Limited (ASX:OSH), JB Hi-Fi Limited (ASX:JBH), Carsales.Com Ltd (ASX:CRZ) and Ramsay Health Care Limited (ASX:RHC): 4 solid growth…

    Read more »

    a woman
    ⏸️ Investing

    Is Japara Healthcare Ltd the best healthcare stock to buy today?

    Japara Healthcare Ltd (ASX:JHC) has fallen 6.4% to a new low. Its weakened share price looks more enticing than the…

    Read more »

    Frequently Asked Questions

    Yes, Ramsay Health Care has historically paid two fully franked dividends a year.

    Ramsay Health Care generally pays its shareholder dividends in March and September. 

    Ramsay Health Care Ltd listed on the ASX on 24 September 1997.

    RHC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Ramsay Health Care Ltd

    Ramsay Health Care Ltd (ASX: RHC) is one of the largest private healthcare providers in the world, with around 500 facilities across 11 countries. Its operations cover Australia, Europe, the UK, and Asia. 

    As well as private hospitals, Ramsay operates day surgeries, primary care clinics, diagnostic and imaging centres, mental health facilities, pharmacies, and an expanding range of in-home and community care services.

    It is the largest private hospital group in Australia, France, and the Scandanavian countries. Its 52.5%-owned subsidiary Ramsay Sante oversees its European operations. Its UK business includes mental health facilities and a range of clinical specialties.

    The vast majority of the company's revenue is generated from its Australian and European operations.

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    15 Dec 2025 Natalie Davis Issued 74,075 $2,618,551
    Issue of securities. 131,547 Performance Rights
    26 Nov 2025 Natalie Davis Issued 21,071 $675,011
    Director remuneration. VWAP

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David Ingle Thodey Non-Executive DirectorNon-Executive Chairman Nov 2017
    Mr Thodey is a business leader focused on innovation, technology, digital transformation, and corporate governance, with more than 40 years of experience. In addition to being Chair he is currently Chair of Xero Limited, Chancellor the University of Sydney, and co-Chair of the Great Barrier Reef Foundation. He is also a non-executive member of the Reserve Bank of Australia Governance Board. He is Chair of Governance Committee.
    Ms Catriona Alison Deans Non-Executive Director Nov 2018
    Ms Deans has 25 years of experience building technology-enabled businesses involved in media, ecommerce, financial services, and health, and across leadership roles as an executive, a director and in venture capital. She is also Chair of Cochlear Limited, Chair of Calix Limited and a Non-Executive Director of Fitness Passport, The Observership Program and Deputy Pty Ltd. She is also a Venture Partner of Main Sequence Ventures. In her executive career, she was previously the CEO of eBay Australia and New Zealand, CEO of eCorp Limited (a publicly listed portfolio of digital businesses), CEO of Hoyts Cinemas and most recently CEO of Netus Pty Ltd (a technology investment company acquired by Fairfax). She also spent seven years as a consultant with McKinsey and Company. She is also a member of Governance Committee.
    Mr Michael Stanley Siddle Non-Executive Director May 1975
    Mr Siddle has experience in the management of private hospitals and has been involved in expansion through developments, mergers and acquisitions. He is also member of Governance Committee.
    Mr Craig Milton Drummond Non-Executive Director Jul 2025
    Mr Drummond brings executive and board-level experience across healthcare, financial services, and other regulated industries. He is also Chair of Transurban Group, Chair of the Australian Foundation Investment Company Limited, and Chair of The Ian Potter Foundation. He has previously served as President and Director of the Geelong Football Club Ltd, a Director of the Florey Institute of Neuroscience and Mental Health, and a Member of the Federal Government's Financial Regulator Assessment Authority. His executive career includes five years as Chief Executive Officer of Medibank Private Ltd (2016-2021). He was formerly Group Executive Finance and Strategy at National Australia Bank, and Chief Executive Officer and Country Head at Bank of America Merrill Lynch (Australia).
    Ms Helen Kurincic Non-Executive Director Mar 2024
    Ms Kurincic is member of Risk Management Committee. She brings operational, executive and board-level experience in a range of Australian based healthcare organisations. In addition to serving on the Ramsay Board, she is currently Chair of McMillan Shakespeare and a director of Carlton Football Club. Her previous health sector roles include Non-Executive Director of private health insurer HBF Health, Estia Health, Integral Diagnostics (Chair), Sirtex Medical, Domain Principal Group, public hospital service provider Melbourne Health, Orygen Youth Mental Health Research Centre and DCA Group.
    Ms Karen Lee Collett Penrose Non-Executive Director Mar 2020
    Ms Penrose is member of Risk Management Committee. She has had an executive career in leadership and CFO roles, in financial services. She has experience in financial management, customer outcomes and operating in a rapidly changing regulatory environment which stems from 20 years in banking with Commonwealth Bank and HSBC and eight years as a listed-company CFO. She has been a full-time director since 2014 and is a committee chair of audit and risk.
    Mr Steven Andrew Sargent Non-Executive Director Nov 2021
    Mr Sargent is Chair of Risk Management Committee. His executive career included 22 years at General Electric, where he gained multi-industry, international experience leading businesses in industries including healthcare, energy and financial services across the USA, Europe, and Asia Pacific. In addition to being a Non-Executive Director of Ramsay, he also serves as a Director of Ramsay Generale de Sante and is the Chair of infection prevention company Nanosonics Limited. His unlisted board activities include Chairman of The Origin Foundation Limited, Origin's philanthropic arm, and Non-Executive Director of The Great Barrier Reef Foundation.
    Ms Claudia Ricarda Rita Sussmuth Dyckerhoff Non-Executive Director Oct 2018
    Ms Dyckerhoff brings expertise in market growth strategies, business development and operational performance improvement in hospitals. She has global experience in hospitals and health care across Europe, Asia, and the USA. She joined McKinsey & Company in Switzerland in 1995 and transferred to the USA focusing on supporting health care companies, including pharmaceutical/medical device companies, payor, provider and health systems in Europe and the USA. In 2006, she transferred to China, was elected Senior Partner in 2010 and supported health care companies as well as governments across Asia. She is member of Risk Management Committee.
    Mr Natalie Davis Chief Executive OfficerManaging Director Dec 2024
    Ms Davis has experience driving strategic transformation, customer focus and growth. She joined Ramsay after a decade with the Woolworths Group, where she held several roles including as Managing Director of Woolworths Supermarkets, Chief Customer Transformation Officer and Managing Director Woolworths NZ.
    Ms Henrietta Rowe Company SecretaryGroup General Counsel Jun 2019
    -
    Michael Hirner Acting Group Executive Finance
    -
    Henrietta Rowe Company SecretaryGroup General Counsel
    -
    Brindan Suresh Group Executive Health and Strategy
    -
    Colleen Harris Group Executive People and Sustainability
    -
    Pascal Roche Managing Director Ramsay Sante
    -
    Nick Costa Managing Director UK Hospitals Acting Managing Director Elysium
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 48,815,874 21.15%
    J P Morgan Nominees Australia Pty Limited 36,515,720 15.82%
    Netwealth Investments Limited <Wrap Services A/C> 33,792,188 14.64%
    Paul Ramsay Holdings Pty Limited 22,346,876 9.68%
    Citicorp Nominees Pty Limited 8,187,680 3.55%
    National Nominees Limited 7,230,630 3.13%
    Woolwich Investments Pty Ltd <The Siddle Family Trust> 3,238,259 1.40%
    BNP Paribas Noms Pty Ltd 3,147,220 1.36%
    Washington H Soul Pattinson And Company Limited 2,758,806 1.20%
    BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 2,750,000 1.19%
    Argo Investments Limited 2,747,673 1.19%
    BNP Paribas Nominees Pty Ltd <Agency Lending Collateral > 2,721,314 1.18%
    Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> 2,057,299 0.89%
    Custodial Services Limited <Beneficiaries Holding A/C> 1,028,000 0.45%
    HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 780,296 0.34%
    BNP Paribas Nominees Pty Ltd <Agency Lending A/C> 721,395 0.31%
    HSBC Custody Nominees (Australia) Limited Gsi Eda 710,830 0.31%
    Australian Foundation Investment Company Limited 625,740 0.27%
    UBS Nominees Pty Ltd 575,000 0.25%
    Certane Ct Pty Ltd <Ramsay Unallocated Ac> 574,899 0.25%

    Profile

    since

    Note